Search hospitals > New York > New York
Memorial Sloan Kettering Cancer Center
Claim this profileNew York, New York 10065
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lymphoma
Conducts research for Tumors
Conducts research for Leukemia
4169 reported clinical trials
429 medical researchers
Summary
Memorial Sloan Kettering Cancer Center is a medical facility located in New York, New York. This center is recognized for care of Cancer, Breast Cancer, Lymphoma, Tumors, Leukemia and other specialties. Memorial Sloan Kettering Cancer Center is involved with conducting 4,169 clinical trials across 1,663 conditions. There are 429 research doctors associated with this hospital, such as Christopher J. Forlenza, Andrea Cercek, MD, Ira Dunkel, MD, and Thomas Kaley, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
Christopher J. ForlenzaMemorial Sloan Kettering Cancer Center7 years of reported clinical research
Expert in Lymphoma
Expert in Langerhans Cell Histiocytosis
18 reported clinical trials
38 drugs studied
Andrea Cercek, MDMemorial Sloan Kettering Cancer Center4 years of reported clinical research
Expert in Colorectal Cancer
Studies Rectal Cancer
15 reported clinical trials
31 drugs studied
Ira Dunkel, MDMemorial Sloan Kettering Cancer Center8 years of reported clinical research
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
14 reported clinical trials
27 drugs studied
Thomas Kaley, MDMemorial Sloan Kettering Cancer Center5 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
14 reported clinical trials
22 drugs studied
Clinical Trials running at Memorial Sloan Kettering Cancer Center
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Esophageal Carcinoma
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Cancer
Astrocytoma
Brain Tumor
Colorectal Cancer
Proton Therapy vs Photon Radiation
for Esophageal Cancer
This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.
Recruiting2 awards Phase 31 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Sloan Kettering Cancer Center?
Memorial Sloan Kettering Cancer Center is a medical facility located in New York, New York. This center is recognized for care of Cancer, Breast Cancer, Lymphoma, Tumors, Leukemia and other specialties. Memorial Sloan Kettering Cancer Center is involved with conducting 4,169 clinical trials across 1,663 conditions. There are 429 research doctors associated with this hospital, such as Christopher J. Forlenza, Andrea Cercek, MD, Ira Dunkel, MD, and Thomas Kaley, MD.
Where is Memorial Sloan Kettering Cancer Center located?
Memorial Sloan Kettering Cancer Center is situated at 1275 York Avenue, New York, NY, nestled between 67th and 68th streets. For the main entrance, head south on York Avenue and make a right turn onto East 66th Street. The parking garage is conveniently located a quarter block from the corner, on the right side of 66th Street.
Who should I call to ask about financial aid or insurance network?
Memorial Sloan Kettering Cancer Center (MSK) offers comprehensive support for patients, including:
- **Insurance Assistance**: For queries, contact 800-525-2225.
- **Financial Assistance Program (FAP)**: Helps manage treatment costs based on income and assets. Apply by calling 646-227-3378.
- **Prescription Assistance**: Aids patients with high medication co-pays.
- **Social Worker Support**: Offers emotional support and practical assistance, including transportation and financial issues.
What insurance does Memorial Sloan Kettering Cancer Center accept?
Memorial Sloan Kettering Cancer Center (MSK) accepts various insurance plans, including Medicare and Medicaid. Patients are responsible for co-insurance, deductible costs for Medicare, and co-payments for Medicaid. MSK has relationships with many insurance providers, including Aetna, Blue Cross Blue Shield, Cigna, and UnitedHealthcare, among others. For specific plan participation and financial assistance options, please contact MSK directly. For insurance inquiries, call 646-497-9176; for billing questions, call 646-227-3378, Monday through Friday.
What awards or recognition has Memorial Sloan Kettering Cancer Center received?
Memorial Sloan Kettering Cancer Center (MSK) is renowned for its groundbreaking research and exceptional care, leading over 900 clinical trials aimed at enhancing treatment for adult and pediatric cancers. From 1980 to 2015, the US Food and Drug Administration approved ten drugs developed by MSK, showcasing an unmatched success rate among cancer centers. Additionally, MSK scientists have earned national and international accolades for their pioneering contributions to science and medicine.